Fast Five Quiz: Alzheimer's Disease Biomarkers

Shaheen E. Lakhan, MD, PhD, MS, MEd


August 29, 2023

Alzheimer's disease (AD) is the most common form of dementia, with prevalence increasing at a dramatic rate. To date, there are no curative treatments available once diagnosis is made. However, current treatment options might slow disease progression. As such, early diagnosis is imperative. Current diagnostic practices are evolving to better predict disease risk before symptom onset and functional impairments. The continued development of biomarkers for widespread use of early detection of AD, particularly to identify disease risk and subclinical disease, are imperative.

How much do you know about biomarkers in AD? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.